Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▲ | Potential |
|---|---|---|---|---|---|---|---|
| R1 RCM Inc. | 19 | 0 | 2 | 0 | €11.40 | €17.21 | 50.988% |
| Kala Pharmaceuticals Inc. | 4 | 0 | 0 | 0 | €6.09 | €19.86 | 226.189% |
| Fagron N.V. | 1 | 0 | 0 | 0 | €18.34 | €20.00 | 9.051% |
| MacroGenics Inc. | 11 | 0 | 3 | 0 | €14.20 | €20.00 | 40.845% |
| Evolus Inc | 6 | 1 | 1 | 1 | €10.90 | €20.26 | 85.829% |
| Fresenius Medical Care AG & Co KGaA ADR | 3 | 1 | 1 | 0 | €19.50 | €21.00 | 7.692% |
| Stoke Therapeutics Inc | 13 | 1 | 2 | 0 | €11.10 | €21.00 | 89.222% |
| Iovance Biotherapeutics Inc. | 19 | 3 | 0 | 0 | €12.18 | €22.78 | 87.066% |
| Avadel Pharmaceuticals plc ADR | 1 | 0 | 0 | 0 | €15.10 | €23.00 | 52.318% |
| Myriad Genetics | 5 | 2 | 0 | 0 | €18.10 | €23.22 | 28.273% |
| Catalyst Pharmaceutical Partners Inc | 10 | 0 | 0 | 0 | €14.00 | €23.46 | 67.599% |
| Owens & Minor Inc. | 2 | 1 | 0 | 0 | €22.20 | €24.04 | 8.298% |
| Deciphera Pharmaceuticals | 6 | 0 | 1 | 0 | €23.40 | €24.97 | 6.723% |
| Exelixis Inc. | 17 | 0 | 2 | 0 | €20.62 | €25.64 | 24.322% |
| Anika Therapeutics | 4 | 0 | 0 | 0 | €24.60 | €26.58 | 8.054% |
| Enanta Pharmaceuticals Inc. | 5 | 4 | 0 | 1 | €12.70 | €26.92 | 111.996% |
| Verastem Inc. | 9 | 0 | 0 | 0 | €8.60 | €27.03 | 214.314% |
| TG Therapeutics Inc. | 22 | 4 | 5 | 0 | €15.64 | €28.06 | 79.441% |
| EyePoint Pharmaceuticals Inc. | 14 | 1 | 0 | 1 | €18.58 | €28.17 | 51.602% |
| Healthstream Inc. | 4 | 0 | 0 | 0 | €25.40 | €29.29 | 15.326% |
| Innoviva Inc. | 3 | 0 | 0 | 0 | €14.20 | €30.00 | 111.268% |
| Xencor Inc. | 9 | 1 | 1 | 0 | €18.70 | €31.74 | 69.727% |
| Patterson Companies Inc. | 6 | 0 | 0 | 0 | €23.80 | €32.18 | 35.219% |
| Alkermes plc | 12 | 2 | 1 | 0 | €22.00 | €34.08 | 54.912% |
| Abeona Therapeutics Inc. | 3 | 1 | 1 | 0 | €3.80 | €34.41 | 805.595% |